Ezekiel Emanuel | Academic Influence

Ezekiel Emanuel's AcademicInfluence.com Rankings

Ezekiel Emanuel

Political Science

#695

World Rank

#886

Historical Rank

#371

USA Rank

political-science Degrees

Ezekiel Emanuel

Philosophy

#1461

World Rank

#2657

Historical Rank

#590

USA Rank

Logic

#796

World Rank

#1332

Historical Rank

#282

USA Rank

philosophy Degrees

Download Badge

Political Science
Philosophy

Ezekiel Emanuel's Degrees

Doctorate Medicine Harvard University

Why Is Ezekiel Emanuel Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ezekiel Jonathan "Zeke" Emanuel is an American oncologist, bioethicist and senior fellow at the Center for American Progress. He is the current Vice Provost for Global Initiatives at the University of Pennsylvania and chair of the Department of Medical Ethics and Health Policy. Previously, Emanuel served as the Diane and Robert Levy University Professor at Penn. He holds a joint appointment at the University of Pennsylvania School of Medicine and the Wharton School and was formerly an associate professor at the Harvard Medical School until 1998 when he joined the National Institutes of Health.

(See a Problem?)

Ezekiel Emanuel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Four models of the physician-patient relationship. (1992) (2239)
Fair Allocation of Scarce Medical Resources in the Time of Covid-19. (2020) (2236)
What makes clinical research ethical? (2000) (2213)
Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. (2016) (1651)
Interventions to improve research participants' understanding in informed consent for research: a systematic review. (2004) (982)
What makes clinical research in developing countries ethical? The benchmarks of ethical research. (2004) (868)
Advance directives for medical care--a case for greater use. (1991) (783)
Are Racial and Ethnic Minorities Less Willing to Participate in Health Research? (2005) (717)
Principles for allocation of scarce medical interventions (2009) (698)
Shared decision making to improve care and reduce costs. (2013) (676)
Symptoms and suffering at the end of life in children with cancer. (2000) (551)
The promise of a good death (1998) (546)
The MOOC Phenomenon: Who Takes Massive Open Online Courses and Why? (2013) (469)
Understanding Economic and Other Burdens of Terminal Illness: The Experience of Patients and Their Caregivers (2000) (450)
Attitudes and Practices of Euthanasia and Physician-Assisted Suicide in the United States, Canada, and Europe. (2016) (436)
Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. (2000) (435)
Preserving the physician-patient relationship in the era of managed care. (1995) (419)
Risks and benefits of phase 1 oncology trials, 1991 through 2002. (2005) (399)
Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. (2016) (374)
The economics of dying. The illusion of cost savings at the end of life. (1994) (367)
Assistance from family members, friends, paid care givers, and volunteers in the care of terminally ill patients. (1999) (357)
Euthanasia and physician-assisted suicide: attitudes and experiences of oncology patients, oncologists, and the public (1996) (346)
Attitudes and desires related to euthanasia and physician-assisted suicide among terminally ill patients and their caregivers. (2000) (345)
The perfect storm of overutilization. (2008) (343)
The Medical Directive. A new comprehensive advance care document. (1989) (335)
The ethics of placebo-controlled trials--a middle ground. (2001) (328)
Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. (2001) (314)
Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? (2006) (298)
What Is Accountability in Health Care? (1996) (291)
Chemotherapy Use among Medicare Beneficiaries at the End of Life (2003) (274)
Cost savings at the end of life. What do the data show? (1996) (270)
Health care reform and cost control. (2010) (269)
Proxy decision making for incompetent patients. An ethical and empirical analysis. (1992) (268)
Quantifying the harmful effect of psoriasis on health-related quality of life. (2002) (262)
The Affordable Care Act and the Future of Clinical Medicine: The Opportunities and Challenges (2010) (251)
Cost of Joint Replacement Using Bundled Payment Models (2017) (247)
Understanding the experience of pain in terminally ill patients (2001) (235)
Racial and ethnic differences in end-of-life costs: why do minorities cost more than whites? (2009) (228)
Influence of age on Medicare expenditures and medical care in the last year of life. (2001) (227)
The Oxford Textbook of Clinical Research Ethics (2008) (225)
Prescribing “placebo treatments”: results of national survey of US internists and rheumatologists (2008) (218)
Protecting Communities in Biomedical Research (2000) (217)
Online education: MOOCs taken by educated few (2013) (214)
Place of death: U.S. trends since 1980. (2004) (206)
Opening Remarks (2015) (205)
An ethical framework for global vaccine allocation (2020) (201)
Protecting communities in research: current guidelines and limits of extrapolation (1999) (197)
Talking with terminally ill patients and their caregivers about death, dying, and bereavement: is it stressful? Is it helpful? (2004) (195)
A systemic approach to containing health care spending. (2012) (193)
The debate over research on stored biological samples: what do sources think? (2002) (184)
Oversight of Human Participants Research: Identifying Problems To Evaluate Reform Proposals (2004) (182)
Ethics of phase 1 oncology studies: reexamining the arguments and data. (2003) (176)
COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries. (2020) (173)
Euthanasia and physician-assisted suicide: a review of the empirical data from the United States. (2002) (171)
Managed care, hospice use, site of death, and medical expenditures in the last year of life. (2002) (170)
Who Should Get Influenza Vaccine When Not All Can? (2006) (169)
The Inevitable Reimagining of Medical Education. (2020) (164)
Using Behavioral Economics to Design Physician Incentives That Deliver High-Value Care (2016) (163)
Undue Inducement: Nonsense on Stilts? (2005) (162)
Patients' decision-making process regarding participation in phase I oncology research. (2006) (161)
Attitudes and Practices of U.S. Oncologists regarding Euthanasia and Physician-Assisted Suicide (2000) (158)
Fairly Prioritizing Groups for Access to COVID-19 Vaccines. (2020) (158)
Attitudes and practices concerning the end of life: a comparison between physicians from the United States and from The Netherlands. (2000) (157)
Moral standards for research in developing countries: from "reasonable availability" to "fair benefits". (2004) (156)
The costs of conducting clinical research. (2003) (154)
The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries (2012) (153)
The obligation to participate in biomedical research. (2009) (149)
Paying Research Subjects: An Analysis of Current Policies (2002) (147)
Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. (2004) (140)
Patients' views on financial conflicts of interest in cancer research trials. (2006) (140)
Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. (2014) (138)
Ethical issues concerning research in complementary and alternative medicine. (2004) (137)
Quality-improvement research and informed consent. (2008) (135)
Shortening medical training by 30%. (2012) (134)
Public health, universal health coverage, and Sustainable Development Goals: can they coexist? (2015) (132)
The practice of euthanasia and physician-assisted suicide in the United States: adherence to proposed safeguards and effects on physicians. (1998) (131)
How well is the Patient Self-Determination Act working?: an early assessment. (1993) (129)
Community permission for medical research in developing countries. (2005) (128)
Euthanasia. Historical, ethical, and empiric perspectives. (1994) (127)
Undue inducement in clinical research in developing countries: is it a worry? (2005) (126)
Artificial Intelligence in Health Care: Will the Value Match the Hype? (2019) (124)
Ending Concerns about Undue Inducement (2004) (123)
Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit. (2005) (121)
Ethics: Fair benefits for research in developing countries: Participants in the 2001 conference on ethical aspects of research in developing countries (2002) (120)
An ethical framework for biomedical research (2008) (118)
Ethical considerations of experimental interventions in the Ebola outbreak (2014) (117)
Advance directives. Stability of patients' treatment choices. (1994) (117)
Reforming the regulations governing research with human subjects. (2011) (112)
Improving long-term psychiatric care: bring back the asylum. (2015) (110)
Concise screening questions for clinical assessments of terminal care: the needs near the end-of-life care screening tool. (2001) (110)
The ethics of paying for children's participation in research. (2002) (109)
Conflicts of Interest for Patient‐Advocacy Organizations (2017) (108)
Research with stored biological samples: what do research participants want? (2005) (106)
Evaluating the risks of clinical research. (2010) (105)
Physicians, Not Conscripts — Conscientious Objection in Health Care (2017) (105)
Do physicians have an obligation to treat patients with AIDS? (1988) (103)
The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs? (2004) (103)
The History of Euthanasia Debates in the United States and Britain (1994) (103)
An analysis of U.S. practices of paying research participants. (2005) (102)
The patents-based pharmaceutical development process: rationale, problems, and potential reforms. (2005) (101)
The End of Radiology? Three Threats to the Future Practice of Radiology. (2016) (101)
Descriptions of benefits and risks in consent forms for phase 1 oncology trials. (2002) (100)
The 2000 revision of the Declaration of Helsinki: a step forward or more confusion? (2001) (98)
A review of the ethical and legal aspects of terminating medical care. (1988) (93)
The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges. (2013) (90)
Exploitation and Developing Countries: The Ethics of Clinical Research (2008) (89)
Justice and managed care. Four principles for the just allocation of health care resources. (2000) (83)
What terminally ill patients care about: toward a validated construct of patients' perspectives. (2000) (83)
The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports"). (2020) (82)
Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer. (2013) (82)
US Public Attitudes Toward COVID-19 Vaccine Mandates (2020) (82)
Racial and ethnic differences in hospice use among patients with heart failure. (2010) (80)
Institutional conflict of interest. (1995) (80)
Where are the health care cost savings? (2012) (80)
Essential elements of a technology and outcomes assessment initiative. (2007) (79)
Brain leaks and consumer neurotechnology (2018) (76)
Ethical and regulatory aspects of clinical research : readings and commentary (2003) (76)
Physician autonomy and health care reform. (2012) (76)
The Ethics of International Research with Abandoned Children (2007) (74)
Clarifying Confusions about Coercion (2005) (73)
Health care vouchers--a proposal for universal coverage. (2005) (73)
Tier 4 drugs and the fraying of the social compact. (2008) (71)
Can Primary Care Visits Reduce Hospital Utilization Among Medicare Beneficiaries at the End of Life? (2008) (71)
Changing premed requirements and the medical curriculum. (2006) (71)
Severe acute respiratory syndrome: providing care in the face of uncertainty. (2003) (71)
Comprehension and informed consent: assessing the effect of a short consent form. (2010) (70)
The Ends of Human Life: Medical Ethics in a Liberal Polity (1991) (69)
Advance Directives: Stability of Patients' Treatment Choices (1994) (67)
Views of potential subjects toward proposed regulations for clinical research with adults unable to consent. (2002) (67)
Why patients continue to participate in clinical research. (2008) (64)
Who really pays for health care? The myth of "shared responsibility". (2008) (63)
Medical Ethics in the Era of Managed Care: The Need for Institutional Structures Instead of Principles for Individual Cases (1995) (62)
A Historic Moment for Open Science: The Yale University Open Data Access Project and Medtronic (2013) (62)
Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access (2021) (62)
Physician Peer Comparisons as a Nonfinancial Strategy to Improve the Value of Care. (2016) (62)
Models of the Physician-Patient Relationship-Reply (1992) (59)
Ethical guidelines for physician compensation based on capitation. (1998) (58)
Managed competition and the patient-physician relationship. (1993) (58)
Stability of attitudes regarding physician-assisted suicide and euthanasia among oncology patients, physicians, and the general public. (1999) (58)
Four Paradigms of Clinical Research and Research Oversight (2006) (57)
Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies (2015) (57)
Reassessing the Data on Whether a Physician Shortage Exists. (2017) (57)
Considering Usual Medical Care in Clinical Trial Design (2009) (56)
No Margin, No Mission: Health Care Organizations and the Quest for Ethical Excellence (2003) (56)
The quality of informed consent in a clinical research study in Thailand. (2005) (56)
A phase I trial on the ethics of phase I trials. (1995) (53)
Vaccine nationalism and the dynamics and control of SARS-CoV-2 (2021) (53)
Decisions at the end of life. Guided by communities of patients. (1993) (52)
Quality of parental consent in a Ugandan malaria study. (2005) (52)
Media exposure and tobacco, illicit drugs, and alcohol use among children and adolescents: a systematic review. (2010) (51)
Disclosing a diagnosis of cancer: where and how does it occur? (2010) (50)
Why There Are No “Potential” Conflicts of Interest (2017) (50)
Field Notes (2000) (50)
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. (2008) (49)
Association of Hospital Participation in a Medicare Bundled Payment Program With Volume and Case Mix of Lower Extremity Joint Replacement Episodes (2018) (49)
The Current State of Medical School Education in Bioethics, Health Law, and Health Economics (2008) (49)
Medicare's requirement for research participation as a condition of coverage: is it ethical? (2006) (49)
Participants in phase 1 oncology research trials: are they vulnerable? (2008) (48)
The cost of institutional review boards in academic medical centers. (2005) (47)
Living Wills: Past, Present, and Future (1990) (47)
A National Strategy for the "New Normal" of Life With COVID. (2022) (47)
Is emergency research without initial consent justified?: the consent substitute model. (2010) (46)
Patient Demands and Requests for Cancer Tests and Treatments. (2015) (45)
Advance Directives: Can Patients' Stated Treatment Choices Be Used to Infer Unstated Choices? (1994) (44)
Health care reform: why? What? When? (2005) (44)
What are the potential cost savings from legalizing physician-assisted suicide? (1998) (43)
Does Random Treatment Assignment Cause Harm to Research Participants? (2006) (43)
Reconsidering the Declaration of Helsinki (2013) (42)
Measuring the Burden of Health Care Costs on US Families: The Affordability Index. (2017) (42)
Fair Benefits for Research in Developing Countries (2002) (42)
Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research (2017) (42)
Care for dying patients (1997) (41)
Risks of phase I research with healthy participants: A systematic review (2016) (40)
What is a "minor" increase over minimal risk? (2005) (40)
Drug coverage decisions: the role of dollars and values. (2000) (39)
The lessons of SARS. (2003) (39)
Alternative medicine research in clinical practice: a US national survey. (2009) (39)
The Real Cost of the US Health Care System. (2018) (39)
Who's caring for whom? Differing perspectives between seriously ill patients and their family caregivers (2006) (38)
Advance directives for medical care. (1991) (38)
US health aid beyond PEPFAR: the Mother & Child Campaign. (2008) (38)
Does Medicine Overemphasize IQ? (2018) (38)
Empirical issues in informed consent for research (2008) (38)
Risks and benefits associated with novel phase 1 oncology trial designs (2007) (37)
The ethics of research in developing countries: assessing voluntariness (2005) (37)
Public Perspectives on COVID-19 Vaccine Prioritization (2021) (37)
Why accountable care organizations are not 1990s managed care redux. (2012) (36)
The ethics of not hiring smokers. (2013) (36)
The Lessons of SARS (2003) (36)
Survey of oncologists about shortages of cancer drugs. (2013) (36)
Should Society Allow Research Ethics Boards to Be Run As For-Profit Enterprises? (2006) (35)
Spending And Quality After Three Years Of Medicare's Voluntary Bundled Payment For Joint Replacement Surgery. (2019) (34)
Addressing the American health-care cost crisis: role of the oncology community. (2013) (34)
Preserving community in health care. (1997) (34)
Reform of Clinical Research Regulations, Finally. (2015) (33)
Regional ethics organizations for protection of human research participants (2004) (33)
Immunity certification for COVID-19: ethical considerations (2020) (32)
Research ethics: How to treat people who participate in research. (2016) (31)
Research on stored biological samples: the views of Ugandans. (2005) (30)
Money and Distorted Ethical Judgments about Research: Ethical Assessment of the TeGenero TGN1412 Trial (2007) (30)
Reinventing American Health Care: How the Affordable Care Act will Improve our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System (2014) (30)
Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations. (2021) (30)
Why should high-income countries help combat Ebola? (2014) (29)
Characteristics of Hospitals Earning Savings in the First Year of Mandatory Bundled Payment for Hip and Knee Surgery (2018) (29)
Philosophical justifications of informed consent in research (2008) (29)
The general agreement on trade in services: implications for health policymakers. (2004) (28)
How managed care can be ethical. (2001) (28)
Clinical research: Should patients pay to play? (2015) (27)
Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. (2007) (27)
Does the Evidence Make a Difference in Consumer Behavior? Sales of Supplements Before and After Publication of Negative Research Results (2008) (27)
Pain and symptom control. Patient rights and physician responsibilities. (1996) (26)
Reengineering US health care. (2013) (26)
Religion, clinicians, and the integration of complementary and alternative medicines. (2009) (26)
What Is the Great Benefit of Legalizing Euthanasia or Physican‐Assisted Suicide? (1999) (26)
A randomized trial comparing concise and standard consent forms in the START trial (2017) (26)
Will physicians lead on controlling health care costs? (2013) (26)
Community health workers combat readmission. (2012) (26)
Physician desire for euthanasia and assisted suicide: would physicians practice what they preach? (1997) (25)
Depression, euthanasia, and improving end-of-life care. (2005) (25)
Circumcision and HIV prevention research: an ethical analysis (2006) (25)
A communal vision of care for incompetent patients. (1987) (24)
Post-trial access to tested interventions: the views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS study. (2006) (24)
The ethics of Pharmaceutical benefit management. (2001) (24)
Accuracy Of The Relative Value Scale Update Committee's Time Estimates And Physician Fee Schedule For Joint Replacement. (2019) (24)
Association Between the Implementation of a Population-Based Primary Care Payment System and Achievement on Quality Measures in Hawaii. (2019) (24)
What cannot be said on television about health care. (2007) (24)
Phase 1 healthy volunteer willingness to participate and enrollment preferences (2017) (24)
Comparing the understanding of subjects receiving a candidate malaria vaccine in the United States and Mali. (2010) (23)
Protecting patient welfare in managed care: six safeguards. (1998) (23)
Oregon's physician-assisted suicide law. Provisions and problems. (1996) (23)
Comparison Of Hospitals Participating In Medicare's Voluntary And Mandatory Orthopedic Bundle Programs. (2018) (23)
Access and ability to pay: the ethics of a tiered health care system. (2007) (22)
Mandating COVID-19 Vaccination for Health Care Workers (2021) (22)
Improving Access to Health Care: A Consensus Ethical Framework to Guide Proposals for Reform (2007) (22)
PEPFAR and maximizing the effects of global health assistance. (2012) (22)
Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis (2004) (22)
Do physicians have an obligation to treat patients with AIDS? (1988) (21)
Conscientious Objection in Health Care. (2017) (21)
Responsiveness to Host Community Health Needs (2007) (21)
Rethinking the responsiveness requirement for international research (2009) (21)
The ethics of expanding access to cheaper, less effective treatments (2016) (21)
Controlling costs by expanding the medicare acute care episode demonstration. (2014) (20)
Advance directives and cost savings: greater clarity and perpetual confusion. (2012) (19)
Comparing Health Outcomes of Privileged US Citizens With Those of Average Residents of Other Developed Countries (2020) (19)
Spending and quality after three years of Medicare’s bundled payments for medical conditions: quasi-experimental difference-in-differences study (2020) (19)
Drug Reimbursement Regulation in 6 Peer Countries. (2020) (19)
The beginning of the end of principlism. (1995) (19)
Personal and community benefits and harms of research: views from Rakai, Uganda (2007) (19)
The Next Generation of Episode-Based Payments (2017) (19)
Outcomes for individuals turned down for living kidney donation (2018) (19)
Research benefits for hypothetical HIV vaccine trials: The views of Ugandans in the Rakai District. (2008) (18)
Enhancing the WHO's Proposed Framework for Distributing COVID-19 Vaccines Among Countries. (2021) (18)
Factors That Influence Practitioners' Interpretations of Evidence From Alternative Medicine Trials: A Factorial Vignette Experiment Embedded in a National Survey (2010) (18)
Can the United States Buy Better Advance Care Planning? (2015) (18)
Ethics of randomized clinical trials. (1998) (18)
Why well-insured patients should demand value-based insurance benefits. (2007) (18)
Technology licensing: lessons from the US experience. (2005) (17)
Euthanasia: where the Netherlands leads will the world follow? (2001) (17)
The potential exploitation of research participants in high income countries who lack access to health care. (2016) (16)
Publication Ethics During Public Health Emergencies Such as the COVID-19 Pandemic. (2020) (16)
Standing By Our Principles: Meaningful Guidance, Moral Foundations, and Multi-Principle Methodology in Medical Scarcity (2010) (16)
Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients. (2021) (16)
Lowering medical costs through the sharing of savings by physicians and patients: inclusive shared savings. (2014) (16)
The Relative Value Scale Update Committee: Time for an Update. (2019) (16)
The cost-coverage trade-off: "it's health care costs, stupid". (2008) (16)
Choice and representation in health care. (1999) (16)
Managing End‐of‐Life Care: Comparing the Experiences of Terminally Ill Patients in Managed Care and Fee for Service (2002) (16)
Revisions of and clarifications to the ASCO conflict of interest policy. (2006) (15)
Enhancing professionalism through management. (2015) (15)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score. (2021) (15)
Global Health Priority-Setting (2019) (15)
Where civic republicanism and deliberative democracy meet. (1996) (15)
The concept of conflicts of interest (2008) (15)
Key Ethical Concepts and Their Application to COVID-19 Research (2020) (15)
Assessing The Effectiveness Of Peer Comparisons As A Way To Improve Health Care Quality. (2020) (15)
Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance (2019) (15)
WHAT CRITERIA SHOULD GUIDE DECISION MAKERS FOR INCOMPETENT PATIENTS? (1988) (15)
The prognosis for changes in end-of-life care after the Schiavo case. (2005) (15)
Association of Social Mobility With the Income-Related Longevity Gap in the United States (2020) (14)
Empirical Studies on Euthanasia and Assisted Suicide (1995) (14)
Patterns of care studies: creating "an environment of watchful concern". (2003) (14)
Whose right to die? (1997) (14)
The Status of End-of-Life Care in the United States: The Glass Is Half Full (2018) (14)
Ethical Guidance on the Use of Life-Sustaining Therapies for Patients With Ebola in Developed Countries (2015) (14)
A consent form template for phase I oncology trials. (2009) (14)
Exploitation and Developing Countries (2008) (14)
Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials (2021) (14)
Sharing Patient Data Without Exploiting Patients. (2020) (14)
Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration. (2019) (14)
Protecting Communities in Research: From a New Principle to Rational Protections (2005) (14)
Death and dignity: dogma disputed (2002) (14)
Global Health Priority-Setting: Beyond Cost-Effectiveness (2020) (14)
Introduction to occupational medical ethics. (2002) (14)
Euthanasia and physician‐assisted suicide: focus on the data (2017) (14)
The Problem with Single-Payer Plans (2008) (13)
Benefits and Burdens of Participation in a Longitudinal Clinical Trial (2009) (13)
What are the obligations of pharmaceutical companies in a global health emergency? (2021) (13)
Review of the American College of Physicians Ethics Manual, Sixth Edition (2012) (13)
Next Phase in Effective Cost Control in Health Care. (2019) (13)
How Can the United States Spend Its Health Care Dollars Better? (2016) (13)
Price and Utilization: Why We Must Target Both to Curb Health Care Costs (2012) (13)
Securing patients' right to refuse medical care: in praise of the Cruzan decision. (1992) (13)
Physician practice variation under orthopedic bundled payment. (2018) (12)
When Is The Price Of A Drug Unjust? The Average Lifetime Earnings Standard. (2019) (12)
Informed consent: practices and views of investigators in a multinational clinical trial. (2005) (12)
Prevention and Cost Control (2012) (12)
Global Justice and Bioethics (2012) (12)
Alternative Payment Models-Victims of Their Own Success? (2020) (11)
Reforming American Medical Education. (2017) (11)
A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics. (2022) (11)
Commentary--Evaluating Community-Based Health Initiatives: Identifying the Characteristics of Successful Initiatives and Evaluations (2002) (11)
Human Trials: Scientists, Investors, and Patients in the Quest for a Cure (2001) (11)
Legal reforms necessary to promote delivery system innovation. (2008) (11)
Getting the next version of payment policy "right" on the road toward accountable cancer care. (2014) (11)
The Ethics of Research on Enhancement Interventions (2010) (11)
A Middle Ground for Accelerated Drug Approval-Lessons From Aducanumab. (2021) (10)
Is justice enough? Ends and means in bioethics. (1996) (10)
Assessing the ethical and practical wisdom of surrogate consent for living organ donation. (2004) (10)
SHOULD PHYSICIANS WITHHOLD LIFE-SUSTAINING CARE FROM PATIENTS WHO ARE NOT TERMINALLY ILL? (1988) (10)
The Case for Resource Sensitivity: Why It Is Ethical to Provide Cheaper, Less Effective Treatments in Global Health. (2017) (10)
Better Late Than Never: Trends in COVID-19 Infection Rates, Risk Perceptions, and Behavioral Responses in the USA (2021) (10)
Choice and Representation in Health Care (1999) (9)
Should Pediatric Patients Be Prioritized When Rationing Life-Saving Treatments During COVID-19 Pandemic (2020) (9)
A National Strategy for COVID-19: Testing, Surveillance, and Mitigation Strategies. (2022) (9)
Employer Decisions and the Seeds of Backlash (1999) (9)
Allocating Medical Resources in the Time of Covid-19. Reply. (2020) (9)
Filthy Lucre or Fitting Offer? Understanding Worries About Payments to Research Participants (2019) (9)
Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability (2021) (9)
The future of biomedical research. (2013) (9)
NCDs and an outcome-based approach to global health (2014) (9)
What does a hip replacement cost?: the transparency imperative in 2013. Comment on "Obtaining consumer prices from US hospitals for a common surgical procedure". (2013) (9)
The future of euthanasia and physician-assisted suicide: beyond rights talk to informed public policy. (1998) (8)
Top five ethical lessons of COVID-19 that the world must learn (2021) (8)
New strategies for aligning physicians with health system incentives. (2016) (8)
National Representativeness Of Hospitals And Markets In Medicare's Mandatory Bundled Payment Program. (2019) (8)
Association of Bundled Payments for Joint Replacement Surgery and Patient Outcomes With Simultaneous Hospital Participation in Accountable Care Organizations (2019) (8)
Is Longer Always Better (2008) (8)
Toward accountable cancer care. (2013) (8)
Institutional review board review of multicenter studies. (2007) (8)
Reconsidering the Declaration of Helsinki – Author' s reply (2013) (7)
The Standard of Care in Multinational Research (2008) (7)
The eligibility of women for clinical research trials. (1995) (7)
WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations (2022) (7)
Refocusing the Responsiveness Requirement (2013) (7)
Is it time for a comprehensive AIDS medical center? (1991) (7)
Overcoming the pricing power of hospitals. (2012) (7)
Book Review Setting Limits Fairly: Can We Learn to Share Medical Resources? By Norman Daniels and James E. Sabin. 191 pp. New York, Oxford University Press, 2002. $32.95. 0-19-514936-X (2002) (7)
Healthcare, Guaranteed: A Simple, Secure Solution for America (2008) (7)
How Well Is the Affordable Care Act Doing?: Reasons for Optimism. (2016) (6)
Redesigning provider payment: Opportunities and challenges from the Hawaii experience. (2018) (6)
Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial (2015) (6)
Nursing home residence confounds gender differences in Medicare utilization an example of Simpson's paradox. (2010) (6)
A Call for Value in Cancer Research. (2016) (6)
ASCO core values. (2006) (6)
The Transparency Imperative (2013) (6)
Six health care trends that will reshape the patient-provider dynamic. (2016) (6)
Outpatient Treatment at Home for Medicare Beneficiaries During and After the COVID-19 Pandemic. (2020) (6)
Characteristics of Physicians Participating in Medicare's Oncology Care Model Bundled Payment Program. (2019) (6)
The NIH and bioethics: what should be done? (2008) (6)
Considering the Future of Price Transparency Initiatives-Information Alone Is Not Sufficient. (2021) (6)
Volume Increases and Shared Decision-making in Joint Replacement Bundles (2018) (6)
Comprar The Oxford Textbook of Clinical Research Ethics | David D. Wendler | 9780199768639 | Oxford University Press (2011) (6)
A world of research subjects. (1998) (6)
Introduction: Why Exploitation? (2008) (6)
COVID-19 and Excess All-Cause Mortality in the US and 20 Comparison Countries, June 2021-March 2022. (2022) (6)
The Blossoming of Bioethics at NIH (1998) (6)
Euthanasia and the care of cancer patients. (1994) (5)
Reform of Clinical Research Regulations. (2016) (5)
Incorporating value into physician payment and patient cost sharing. (2018) (5)
The Ends of Human Life: Medical Ethics in a Liberal (1992) (5)
Real-time Feedback in Pay-for-Performance: Does More Information Lead to Improvement? (2017) (5)
Designing a Successful Primary Care Physician Capitation Model. (2021) (5)
Progress but Many Remaining Challenges (2013) (5)
Informed Consent for Research (2007) (5)
Declaration of Helsinki and protection for vulnerable research participants--reply. (2014) (5)
Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group (2021) (5)
Making cuts to Medicare: the views of patients, physicians, and the public. (2015) (5)
Health policy: Addressing conflicts of interest of public speakers at advisory committee meetings (2016) (5)
Going to the moon in health care: medicine's Big Hairy Audacious Goal (BHAG). (2013) (5)
Global Justice and the “Standard of Care” Debates (2012) (5)
Development and Validation of a Model to Predict Long‐Term Survival After Liver Transplantation (2021) (5)
On the Ethics of Vaccine Nationalism: The Case for the Fair Priority for Residents Framework (2021) (5)
The cost of marginal medicine is too high. (2005) (5)
Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines (2021) (4)
Spillover Effects of Medicare's Voluntary Bundled Payments for Joint Replacement Surgery to Patients Insured by Commercial Health Plans (2020) (4)
Authors' Reply (2006) (4)
A communitarian health-care package. (1993) (4)
Physician-drug company conflict of interest. (1996) (4)
Changes in Outpatient Imaging Utilization and Spending Under a New Population-Based Primary Care Payment Model. (2020) (4)
Use of Single Fraction Radiation Therapy for Bone Metastases, 2006-2012 (2014) (4)
2 – Bioethics in the Practice of Medicine (2012) (4)
How to cure U.S. health care. A voucher plan that covers everyone--and helps businesses too. (2006) (4)
Pricing a Year of Progression-Free Survival: When Is the Cost of Cancer Drugs Unreasonable? (2019) (4)
A new federal-state partnership in health care: real power for states. (2008) (4)
Is Emergency Research Without Initial Consent Justified (2017) (4)
Is There Coercion or Undue Inducement to Participate in Health Research in Developing Countries? An Example from Rakai, Uganda (2009) (4)
Researching a Bioethical Question (2012) (4)
Is our AIDS policy ethical? (1987) (4)
Advance directives [6] (1992) (4)
Ethics in Oncology (2003) (4)
Health Care Reform: Why? What? When? What it might take to effect comprehensive change. (2005) (4)
The moral duty to buy health insurance. (2012) (4)
Prescription for the Future: The Twelve Transformational Practices of Highly Effective Medical Organizations (2017) (4)
Aligning Patient and Physician Incentives (2018) (4)
Euthanasia and Physician-Assisted Suicide: Implications for Physicians (2004) (4)
Assisted suicide and cancer. (2001) (4)
Euthanasia and Physician-Assisted Suicide-In Reply. (2016) (4)
Paying for Cancer Drugs That Prove Their Benefit. (2021) (4)
Health care reform: still possible. (2002) (3)
The Near-Term Future of Health Care Reform. (2021) (3)
Measuring the Quality of Cancer Care: The National Initiative for Cancer Care Quality (NICCQ) (2006) (3)
Cancer and maybe a baby? (1994) (3)
Hospice Carve-In-Aligning Benefits With Patient and Family Needs. (2020) (3)
Commentary on Discussions About Life-Sustaining Treatments (1994) (3)
Conserving Scarce Resources: Willingness of Health Insurance Enrollees to Choose Cheaper Options (2004) (3)
Designing a commercial bundle for cardiac procedures: The Percutaneous Coronary Intervention Episode Payment Model. (2020) (3)
Tiers Without Tears: the Ethics of a Two‐Tier Health Care System (2009) (3)
Correction: Should Society Allow Research Ethics Boards to Be Run As For-Profit Enterprises? (2006) (3)
Hypofractionated whole breast irradiation for early-stage breast cancer--reply. (2015) (3)
9. Addressing Exploitation: Reasonable Availability Versus Fair Benefits (2008) (3)
Compassionate use of experimental drugs in the Ebola outbreak – Authors' reply (2014) (3)
Incentives for Palliative Care. (2022) (3)
Commentary--A Funny Thing Happened on the Way to Managed Competition (2002) (2)
AIDS, Autopsies, and Abandonment (1989) (2)
Research Ethics Boards: Reply from Ezekiel Emanuel (2006) (2)
Spillover effects of mandatory hip and knee replacement surgery bundles in medicare. (2020) (2)
Conflict of interest in industry-sponsored drug development. (2007) (2)
2. Case Studies: The Havrix Trial And The Surfaxin Trial (2008) (2)
Potential Unintended Effects of Medicare's Bundled Payments for Care Improvement Program-Reply. (2019) (2)
Managed Care: Ethical Issues-Reply (1995) (2)
The Case Against Assisted Suicide: For the Right to End-of-Life Care (2003) (2)
Advance directives. (1992) (2)
The Health Reform We Need & Are Not Getting (2009) (2)
Advance directives. (1991) (2)
Conflicts Of Interest And Preserving The Objectivity Of Scientific Research (2004) (2)
Experimental evidence to support (1998) (2)
Assessing the effect of a shorter consent form on comprehension in healthy volunteers (2010) (2)
Ethical conditions for accelerating COVID-19 vaccine research (2020) (2)
Addressing exploitation of poor clinical trial participants in North America and the European Union. (2016) (2)
Correction in response to the review of ethical issues in international biomedical research. (2009) (2)
Care and Cost Savings at the End of Life-Reply (1996) (2)
Designing a commercial medical bundle for cancer care: Hawaii Medical Service Association's Cancer Episode Model. (2020) (2)
The ethical paradox of modern health care Virginia A Sharpe Alan I Faden (1998) (2)
What Are Bioethicists Doing about Health Care Reform? (2008) (2)
What Covid Has Taught the World about Ethics. (2022) (2)
Dilemmas in access to medicines: a humanitarian perspective – Authors' reply (2017) (2)
The Future of Priority-Setting in Global Health (2019) (2)
Chapter 3 – Researching a Bioethical Question (2002) (1)
Phase I participants as a vulnerable population (2004) (1)
Code for Vaccine nationalism and the dynamics and control of SARS-CoV-2 (2021) (1)
Prescribing Our Future: Ethical Challenges in Genetic Counseling (Book) (1994) (1)
Obligations in a global health emergency – Authors' reply (2021) (1)
Recent History of End-of-Life Care and Implications for the Future (2005) (1)
How Managed Care Can Be Ethical When managed care problems are recast as ethical dilemmas, can solutions be far behind? (2001) (1)
Author Correction: Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group (2021) (1)
Patient demand for care: How much does this contribute to inappropriate tests and treatments? (2014) (1)
Living wills: are durable powers of attorney better? (2004) (1)
Ethics of Clinical Oncology Research (2006) (1)
Population-Based Primary Care Payment System in Hawaii-Reply. (2019) (1)
Reply to “Separating neuroethics from neurohype” (2019) (1)
Innovation Legal Reforms Necessary to Promote Delivery System (2008) (1)
Eight is too many: the case against octuplets. (1999) (1)
Use of Life-Sustaining Therapies for Patients With Ebola Virus Disease. (2015) (1)
“Physician-Assisted Suicide among Oregon Cancer Patients”: A Fading Issue (2006) (1)
Physicians advising investment firms. (2005) (1)
Assisted suicide? Not in my state. (1997) (1)
Participating in Biomedical Research—Reply (2009) (1)
Health Care Overutilization in the United States—Reply (2008) (1)
Scientific misconduct in cancer clinical trials. (1998) (1)
Chapter 72 – Ethical Considerations in Managing Critically Ill Patients (2008) (1)
Response to Commentators on “Undue Inducement: Nonsense on Stilts?” (2005) (1)
Assessing Requests for Euthanasia From Terminally Ill Patients—Reply (2001) (1)
Ethical criteria for allocating health-care resources – Authors' reply (2009) (1)
Physician Liability and Taking Rights Seriously (1987) (1)
Accurate long‐term prediction of death for patients with cirrhosis (2022) (1)
The Impact of Voluntary Bundled Payment on Selection for Joint Replacement Surgery Among Socioeconomically Vulnerable Patients (2018) (1)
Medicare Requirement for Research Participation—Reply (2006) (1)
Aligning Incentives for Improving Diagnostic Excellence. (2022) (1)
Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program (2022) (1)
Perspectives on Health Care Reform and the Affordable Care Act (2015) (1)
Distributing US Health Aid—Reply (2009) (1)
A Comparison Between Physicians From the United States and From the Netherlands (2000) (1)
Pitfalls and Potential in Medicare's Move Toward Outpatient Care Episodes (2018) (1)
Outcomes Associated With Overlapping Surgery. (2019) (0)
Reductions in funding for medical research--reply. (2013) (0)
Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply. (2022) (0)
Assessing Alternative Payment Models-Reply. (2020) (0)
Characteristics of Patients Dying With Cancer in Developed Countries--Reply. (2016) (0)
A Pragmatic Policy Trial Testing Larger Bonus Sizes and the Behavioral Economic Principles of Loss Aversion and Social Pressure in Physician Pay-for-Performance (2018) (0)
rheumatologists national survey of US internists and Prescribing " placebo treatments " : results of (2008) (0)
Equitable Global Allocation of Monkeypox Vaccines (2023) (0)
Author Correction: Brain leaks and consumer neurotechnology (2019) (0)
Shortening Medical Education—Reply (2012) (0)
Quality and Spending Under the Population-Based Payments for Primary Care (3PC) System in Hawaii (2019) (0)
A Midwife Through the Dying Process: Stories of Healing and Hard Choices at the End of Life (1997) (0)
Assisted Suicide and Euthanasia (2003) (0)
Terminating Medical Care (2003) (0)
Error in Abstract. Correlation of Smoking- Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer. (2015) (0)
Time For Surgeries: The Authors Reply. (2019) (0)
Physician Time And Payments: The Authors Reply. (2019) (0)
Symposium Keynote Speeches: Opening Remarks (2015) (0)
AAAS Forum on Cloning: June 25, 1997 (1997) (0)
Stability o f A ttitudes R egarding P hysician-Assist ed S uicide and E uthanasia A mong O ncology P atients, P hysicians, and t he G eneral P ublic (2009) (0)
Pediatric Research and the Federal Minimal Risk Standard—Reply (2006) (0)
A Randomized Trial of Peer Comparisons to Improve Guideline-Based Primary Care (2019) (0)
Characteristics of medical oncologists participating in the Oncology Care Model. (2019) (0)
A Time to Die: The Place for Physician Assistance (review) (2000) (0)
Data Error in Figure. (2016) (0)
Campaign US Health Aid Beyond PEPFAR: The Mother & Child (2008) (0)
Strategy for the "New Normal" of Life With COVID-Reply. (2022) (0)
Phase I participants as a vulnerable population. (2004) (0)
Association of Participation in Bundled Payments for Medical Conditions with Changes in Spending and Utilization: A Longer-Term Look at the Bundled Payments for Care Improvement Initiative (2019) (0)
Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder. (2023) (0)
Review Essay Perspectives on health care reform and the Affordable Care Act (2015) (0)
Adequacy of treatment in terminally ill patients (2001) (0)
Patient, public, and oncologists’ attitudes toward rationing medical care. (2013) (0)
Reconfiguring Medical Education-Reply. (2020) (0)
The Medical Directive-Reply (1990) (0)
Moving risk to physicians. (2015) (0)
A Reference in Research Ethics (2004) (0)
67 Responsiveness to Host Community Health Needs (2007) (0)
Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory Trials. (2022) (0)
Author Correction: Brain leaks and consumer neurotechnology (2019) (0)
The Demanding Patient Revisited--Reply. (2015) (0)
Comments on the Affordable Care Act and the Future of Clinical Medicine (2011) (0)
Book Review Mortal Peril: Our inalienable right to health care? By Richard A. Epstein. 503 pp. Reading, Mass., Addison–Wesley, 1997. $27.50. 0-201-13647-3 (1997) (0)
Death's door: the end of euthanasia? (1999) (0)
Euthanasia and the care of cancer patients. (1994) (0)
Importance of Intelligence and Emotional Intelligence for Physicians-Reply. (2018) (0)
Medicare requirement for research participation. Authors' reply (2006) (0)
WENDLER ET AL. RESPOND (2004) (0)
Living wills: are durable powers of attorney better? (2004) (0)
Industrial subcontracting in the Basque Country (2009) (0)
Needs at the End-of-Life Screening Tool (2016) (0)
The Long and Winding Road of Health Care Reform (2015) (0)
Designing the Population-Based Payment for Primary Care (3PC) Program in Hawaii - the Analytic Approach to Payment Model Development (2019) (0)
Changing premedical requirements. Author's reply (2007) (0)
Fair Drug Prices: The Author Replies. (2019) (0)
The painful truth about euthanasia. (1997) (0)
Changing Premedical Requirements—Reply (2007) (0)
The Impact of Co-Participation in Medicare Accountable Care Organization on Spending and Quality in Lower Extremity Joint Replacement Bundles (2019) (0)
Orthopedic Surgery Times: The Authors Reply. (2019) (0)
developing and developed countries landscape . A review of empirical data from The quality of informed consent : mapping the and (0)
Volume Response and Patient Selection in Voluntary Bundled Payment (2018) (0)
The Cruzan decision (1993) (0)
Expanding long-term care options for persons with serious mental illness--reply. (2015) (0)
Transforming Primary Care Payment in Hawaii: A Policy Trial (2018) (0)
Shortage or Surplus of Physicians in the United States-Reply. (2017) (0)
Ugandans in the Rakai District (2016) (0)
Holding Medical Professional Society Scientific Meetings Only in States That Protect Abortion Rights-Clinical and Ethical Considerations. (2023) (0)
Health care cost control and views of physicians--reply. (2013) (0)
Health Care Overutilization in the United States. Authors' reply (2008) (0)
Human Subjects Research (2003) (0)
Vision of Care for Incompetent Patients (2016) (0)
Contributors (2012) (0)
Contributors (2010) (0)
Measures of the Burden of Medical Expenses-Reply. (2018) (0)
Perspective The NEW ENGL A ND JOUR NA L of MEDICI NE (2013) (0)
Public engagement in health policy (2018) (0)
Science Translational Medicine Podcast: 29 July 2015 (2015) (0)
Orthopedic Surgeon Payment: The Authors Reply. (2019) (0)
Fair domestic allocation of monkeypox virus countermeasures (2023) (0)
The standard of care debate: Conceptual clarifications. Authors' reply (2004) (0)
Book Review The Rights of Patients: The Authoritative ACLU Guide to the Rights of Patients (An American Civil Liberties Union Handbook.) Third edition. By George J. Annas. 387 pp. Carbondale, Southern Illinois University Press, 2004. $19.95. 0-8093-2515-2 (2004) (0)
Measuring the Quality of Cancer Care (2006) (0)
Distributing US Health Aid. Authors' reply (2009) (0)
Is health care a commodity? (1997) (0)
Comprehensive Health Care Reform and Biomedical Innovation (2008) (0)
Health Care Reform: Still Possible: Now Might Be the Time, If the Proposal Is Crafted Right (2002) (0)
EUTHANASIA IN THE USA (1999) (0)
Voluntary Bundled Payment for Coronary Artery Bypass Surgery: Do Effects for Joint Replacement Extend to Other Surgical Conditions? (2019) (0)
10. Uma Narayan, Dislocating Cultures: Identities, Traditions, and Third World Feminism Uma Narayan, Dislocating Cultures: Identities, Traditions, and Third World Feminism (pp. 668-671) (1999) (0)
Affordable Drug Prices: The Author Replies. (2019) (0)
FEATURE: HEALTH CARE PAYMENT REFORM IN THE UNITED STATES: TWO VIEWPOINTS: (2014) (0)
Book Review: Reproductive Genetics and the Law (1987) (0)
Euthanasia and physician‐assisted suicide: focus on the data (2017) (0)
Priorities for Public Health Spending-Reply. (2017) (0)
THE CRUZAN DECISION. REPLY (1993) (0)
Principles of Biomedical Ethics (1995) (0)
Ethics and Genetic Research in Africa (2004) (0)
Fulfillment of the uncertainty principle in cancer clinical trials. (2004) (0)
End-of-life care: the authors respond. (2005) (0)
Participants in Phase 1 Oncology Research Trials Are Vulnerable--Reply (2008) (0)
Ethics of Surrogate Consent for Living Organ Donation—Reply (2004) (0)
Death and Dying: A Reader (2004) (0)
Case study. Is longer always better? Commentary. (2008) (0)
The Distinction Between Active and Passive Euthanasia-Reply (1995) (0)
Books received (1993) (0)
A qualitative study of the influence of loss aversion and increased social pressure in physician pay-for-performance (2019) (0)
AAAS Forum on Cloning (1997) (0)
Reform: The Authors Respond (2006) (0)
The Real Cost of the US Health Care System (2018) (0)
Learning from five bad arguments against mandatory vaccination (2023) (0)
Spillover Effects of the Comprehensive Care for Joint Replacement Program Among Non‐Medicare Patients (2020) (0)
THE DISTINCTION BETWEEN ACTIVE AND PASSIVE EUTHANASIA. AUTHOR REPLY (1995) (0)
Patients and Their Caregivers Physician-Assisted Suicide Among Terminally Ill Attitudes and Desires Related to Euthanasia and (2009) (0)
Attitudes a nd P ractices A mong P ediatric O ncologists Regarding E nd-of-Life C are: R esults o f t he 1 998 A merican Society o f C linical O ncology S urvey (2001) (0)
Trends in Enrollment in Employer-Sponsored Health Insurance in the US Before and During the COVID-19 Pandemic, January 2019 to June 2021 (2022) (0)

This paper list is powered by the following services:

Other Resources About Ezekiel Emanuel

en.wikipedia.org

What Schools Are Affiliated With Ezekiel Emanuel?

Ezekiel Emanuel is affiliated with the following schools:

Image Attributions

Image Source for Ezekiel Emanuel